Track record · closed signal

Novavax Inc (NVAX) — closed signal from May 5, 2026

Target reached Published before the outcome was known, scored automatically when the window closed on August 3, 2026.

Predicted vs. what happened

NVAX price · publication thesis → realized outcomesplit-adjusted
$8.09 Published $10.36 Target $7.41 Window close $11.61 Peak
$7.50 – $8.20Entry zone — fair-value band
$8.09Published — price the day we called it
$10.36Target — the price the thesis aimed for
$11.61Peak — highest point inside the window, not a realized return
$7.41Window close — end-of-window price, context only

What happened

Target reached

Reached its target in 3 days.

Peak price
$11.61
peak on May 27, 2026 — not a realized return
Peak gain
+43.4%
peak, from the publication price
Window close
$7.41
end-of-window price, context only
Days to target
3
Window
May 5, 2026 – August 3, 2026

The thesis — published May 5, 2026

Predicted growth
+28%
over the measurement window
Target price
$10.36
the price the thesis aimed for
Entry zone
$7.50 – $8.20
the fair-value band we waited for
Price at publication
$8.09
published May 5, 2026
Confidence
69%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

Novavax's recent shift toward licensing and partnerships with big drugmakers gives a clear chance for big upside if vaccine data and upcoming earnings go well. The company has cash and looks reasonably valued, but biotech results and heavy short interest make outcomes very uncertain. Near-term results are speculative and likely to cause big price swings.

Primary drivers

  • Licensing deals could make revenue steadier and more reliable
  • Deals with Sanofi and Pfizer boost credibility and reach
  • Earnings and vaccine trial updates can move the stock quickly
  • Cash on hand reduces the chance of forced financing

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.